GSA Capital Partners’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Buy
+31,055
New +$137K 0.01% 1604
2025
Q2
Sell
-103,803
Closed -$565K 1964
2025
Q1
$565K Buy
103,803
+29,582
+40% +$168K 0.05% 711
2024
Q4
$367K Buy
+74,221
New +$389K 0.03% 1096
2024
Q2
Sell
-21,902
Closed -$225K 1865
2024
Q1
$225K Buy
+21,902
New +$162K 0.02% 1356
2022
Q2
Sell
-146,955
Closed -$519K 1618
2022
Q1
$519K Buy
+146,955
New +$522K 0.07% 502

Other funds holding LFMD

GSA Capital Partners's LFMD Position: Q2 2026 in Review

GSA Capital Partners opened a new position in LifeMD (LFMD) in Q2 2026: 31,055 shares worth $128K. The stake represents 0.01% of the portfolio and ranks #1604 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in LFMD as recently as Q1 2025.

GSA Capital Partners first reported a position in LFMD in Q1 2022 and has held it in 5 quarters since. The position peaked at $565K in Q1 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • GSA Capital Partners held 31,055 shares of LifeMD worth $128K as of Q2 2026.
  • LifeMD was a new GSA Capital Partners position in Q2 2026.
  • LifeMD made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1604 holding.
  • GSA Capital Partners first reported a position in LifeMD in Q1 2022 and has held it in 5 quarters since.
  • GSA Capital Partners's LifeMD position peaked at $565K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.